Can persistent infection promote autoimmunity?

Persistent or recurrent infection is a biologically credible contributor to autoimmunity, but the evidence is strongest for temporal associations—particularly Epstein–Barr virus (EBV) and multiple sclerosis (MS)—rather than direct proof that ongoing active infection causes autoimmune disease through any single pathway.

Clinical and epidemiologic evidence

• EBV provides the most developed human example. In a longitudinal cohort of more than 10 million people, EBV infection preceded nearly all MS cases and was associated with markedly increased subsequent MS risk.
• A military cohort likewise found EBV infection preceding autoantibodies and clinical systemic lupus erythematosus.
• These observations support EBV as a potential contributor to autoimmune risk, but they do not distinguish effects of persistent active infection from prior infection, latency, or reactivation.

Mechanistic evidence

• Molecular mimicry has the most specific supporting data. EBNA1-directed antibodies and T-cell responses can cross-react with self-antigens relevant to MS, including GlialCAM, CRYAB, MBP, and ANO2. Broader, multi-region EBNA1 immune responses were associated with MS at diagnosis.
• Persistent antigen exposure could sustain lymphocyte stimulation, antigen presentation, inflammatory cytokine signaling, and epitope spreading—conditions capable of maintaining autoreactive immune responses.
• Infection-associated inflammation can also activate nearby non-pathogen-specific lymphocytes (“bystander activation”), potentially lowering the threshold for autoreactivity. These pathways are mechanistically coherent but not directly demonstrated as causal sequences in human autoimmune disease.

Practical interpretation

• Persistent antibodies alone do not establish active infection; PCR results also depend on the pathogen, specimen, timing, and assay sensitivity.
• Bottom line: The claim is plausible with moderate confidence. Molecular mimicry—especially in EBV-associated MS—has the strongest mechanistic human support, while prolonged antigen presentation and bystander activation remain credible but less directly established explanations for how persistent infection might promote autoimmunity.